» Articles » PMID: 12747962

Regulation of Vascular Permeability by Vascular Endothelial Growth Factors

Overview
Date 2003 May 16
PMID 12747962
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Increased vascular permeability is one of the first stages in both physiological and pathological angiogenesis-the generation of new blood vessels from preexisting vasculature. Although this has been hypothesised to be true in physiological angiogenesis, it is clearly a mark of blood vessel growth in disease. Normal, healthy blood vessel growth (physiological angiogenesis) occurs throughout development as well as during tissue repair and growth in adult tissues. Angiogenesis is also seen in a wide variety of diseases, which include all the major causes of mortality in the West-heart disease, cancer, stroke, vascular disease, and diabetes. Much of this angiogenesis is significantly different from normal blood vessel growth and is termed pathological angiogenesis. Angiogenesis is regulated by vascular growth factors, the most notable being the vascular endothelial growth factor family of proteins (VEGF). These act on specific receptors in the vascular system to stimulate new vessel growth by a number of mechanisms. VEGFs also directly stimulate increased vascular permeability to water and large molecular weight proteins and vasodilatation. These two effects result in a large flux of water and macromolecules from the vasculature to the interstitium, often resulting in oedema. This review will outline the mechanisms by which VEGFs do this and discuss some of the difficulties in interpreting data from VEGF studies due to the conflicting and synergistic effects of these actions.

Citing Articles

Ovarian Hyperstimulation Syndrome (OHSS): A Narrative Review and Legal Implications.

Gullo G, Cucinella G, Stojanovic V, Stojkovic M, Bruno C, Streva A J Pers Med. 2024; 14(9).

PMID: 39338169 PMC: 11433561. DOI: 10.3390/jpm14090915.


An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1.

Moon S, Kim H, Kim J, Kim J, Choi J, Won S PLoS One. 2024; 19(7):e0305466.

PMID: 38990973 PMC: 11239064. DOI: 10.1371/journal.pone.0305466.


Fertility Preservation and Ovarian Hyperstimulation Syndrome Management in Cancer Care: A Pathophysiological Perspective on Gonadotropin-Releasing Hormone Agonists and Antagonists.

Bedoschi G, Ingold C, Navarro P Pathophysiology. 2024; 31(2):288-297.

PMID: 38921726 PMC: 11206524. DOI: 10.3390/pathophysiology31020021.


Detrimental Roles of Hypoxia-Inducible Factor-1α in Severe Hypoxic Brain Diseases.

Choi Y Int J Mol Sci. 2024; 25(8).

PMID: 38674050 PMC: 11050730. DOI: 10.3390/ijms25084465.


Cepharanthine maintains integrity of the blood-brain barrier (BBB) in stroke via the VEGF/VEGFR2/ZO-1 signaling pathway.

Yang Y, Li C, Yang S, Zhang Z, Bai X, Tang H Aging (Albany NY). 2024; 16(7):5905-5915.

PMID: 38517394 PMC: 11042958. DOI: 10.18632/aging.205678.